Abstract
Recently, the important role of T helper 17 (Th17) cells in psoriasis has been clarified; however, the role of IL-17F produced by Th17 cells is still not fully understood. IL-6 exhibits multiple biologic functions, such as regulation of immunological responses including those in psoriatic reactions. Therefore, we examined the production of IL-6 protein in normal human epidermal keratinocytes (NHEKs) stimulated by IL-17F, TNF-α, IL-17A, and IL-17A in combination with TNF-α, and PBS control. We then examined the expression of IL-6 mRNA in mouse skin after intradermal injection of IL-17F. Finally, IL-17F expression in skin biopsy specimens from psoriasis patients was examined by immunohistochemistry. The results showed that IL-17F induced production of IL-6 in NHEKs in a time-dependent manner. This could be attenuated by chimeric inhibitor blocking the IL-17 receptor. The amounts of IL-6 stimulated by IL-17F were much higher than those stimulated by TNF-α or IL-17A. IL-6 was also significantly upregulated via synergistic stimulation with IL-17A plus TNF-α. The expression of IL-6 mRNA 24 h after IL-17F injection in the mouse skin was 3.2-fold higher than that in the control group. Immunohistochemistry of inflammatory cells in the dermis demonstrated a large number of CD4+ T cells showing IL-17F positivity in psoriatic skin lesions, but few or none in non-lesional psoriatic skin. Our results indicate that IL-17F produced by CD4+ T cells causes the inflammation in psoriasis partly through induction of IL-6 in keratinocytes.
Similar content being viewed by others
Abbreviations
- NHEKs:
-
Normal human epidermal keratinocytes
- IL:
-
Interleukin
- Th:
-
T helper
References
Al-Ramli W, Préfontaine D, Chouiali F et al (2009) T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol 123:1185–1187
Blauvelt A (2008) T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis. J Invest Dermatol 128:1064–1067
Chan JR, Blumenschein W, Murphy E et al (2006) IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implication for psoriasis pathogenesis. J Exp Med 203:2577–2587
Cordiali-Fei P, Ardigo M, Mastroianni A et al (2008) Serum cytokines and bioumoral immunological characterization of psoriatic patients in long term etanercept treatment. Int J Immunopathol Pharmacol 21:643–649
Galadari I, Sheriff MO (2005) Estimation of interleukin-6 level in psoriasis patients. Eur Ann Allergy Clin Immunol 37:63–65
Gottlieb AC, Chamian F, Masud S et al (2005) TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques. J Immunol 175:2721–2729
Grossman RM, Krueger J, Yourish D et al (1989) Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86:6367–6371
Gudjonsson JE, Elder JT (2008) Psoriasis. In: Wolff K, Goldsmith LA, Katz SI et al (eds) Fitzpatrick’s Dermatology in general medicine, 7th edn. McGraw-Hill Companies, New York, pp 169–193
Hurst SD, Muchamuel T, Gorman DM et al (2002) New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 169:443–453
Ishigame H, Kakuta S, Nagai T et al (2009) Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30:108–119
Jovanovic DV, Di Battista JA, Martel-Pelletier J et al (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 160:3513–3521
Kawaguchi M, Onuchic LF, Li X-D, Essayan D, Schroeder J, Xiao H-Q et al (2001) Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J Immunol 167:4430–4435
Kawaguchi M, Kokubu F, Odaka M et al (2004) Induction of granulocyte-macrophage colony-stimulating factor by a new cytokine, ML-1 (IL-17F), via Raf I-MEK-ERK pathway. J Allergy Clin Immunol 114:444–450
Koga C, Kabashima K, Shiraishi N et al (2008) Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 128:2625–2630
Krueger GG, Langley RG, Leonardi C et al (2007) A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 356:580–592
Kupper T, Min K, Sehgak P et al (1989) Production of interleukin-6 by keratinocytes. Ann N Y Acad Sci 557:454–465
Leonardi C, Kimball AB, Papp KA et al (2008) Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 371:1665–1674
Ma HL, Liang S, LI J et al (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118:597–607
Mobini N, Toussaint S, Kamino H (2008) Noninfectious erythematous, papular, and squamous diseases. In: Elder DE (ed) Lever’s histopathology of the skin, 10th edn. Lippincott Williams &Wilkins, Philadelphia, pp 174–181
Neuner P, Urbanski A, Trautinger F et al (1991) Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol 97:27–33
Neuner P, Charvat B, Konbler R et al (1994) Cytokine release by peripheral blood mononuclear cells is affected by 8-methoxypsoralen plus UV-A. Photochem Photobiol 59:182–188
Oda N, Canelos PB, Essayan DM et al (2005) Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Am J Respir Crit Care Med 171:12–18
Papp KA, Langley RG, Lebwohl M et al (2008) Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 371:1675–1684
Sigmundsdottir H, Johnston A, Gudjonsson JE, Valdimarsson H (2005) Narrowband-UVB irradiation decreases the production of pro-inflammatory cytokines by stimulated T cells. Arch Dermatol Res 297:39–42
Toy D, Kugler D, Wolfson M et al (2006) Interleukin 17 signals through a heteromeric receptor complex. J Immunol 177:36–39
Watanabe H, Kawaguchi M, Fujishima S et al (2009) Functional characterization of IL-17F as a selective neutrophil attractant in psoriasis. J Invest Dermatol 129:650–656
Williams IR, Rich BE, Kupper TS (2008) Cytokines. In: Wolff K, Goldsmith LA, Katz SI et al (eds) Fitzpatrick’s dermatology in general medicine, 7th edn. McGraw-Hill Companies, pp 115–126
Wilson NJ, Boniface K, Chan JR et al (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8:950–957
Yang XO, Chang SH, Park H et al (2008) Regulation of inflammatory responses by IL-17F. J Exp Med 205:1063–1075
Zaba LC, Cardinale I, Gilleaudeau P et al (2007) Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 204:3183–3194
Zheng Y, Danilenko DM, Valdez P et al (2007) Interleukin-22, a Th17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445:648–651
Zrioual S, Ecochard R, Tournadre A et al (2009) Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes. J Immunol 182:3112–3120
Acknowledgments
This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and, in part, by National Institutes of Health (USA) grant RO1 AI-052468.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fujishima, S., Watanabe, H., Kawaguchi, M. et al. Involvement of IL-17F via the induction of IL-6 in psoriasis. Arch Dermatol Res 302, 499–505 (2010). https://doi.org/10.1007/s00403-010-1033-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-010-1033-8